Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer.
Article in Free Radical Biology and Medicine (May 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Free Radical Biology and Medicine (May 2024)
Article in Nature Communications (July 2022)
Book chapter (October 2021)